Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy Matsuda N; Hattori YJ Pharmacol Sci 2006[Jul]; 101 (3): 189-98In recent years, extensive basic science research has led to a clear understanding of the molecular mechanisms contributing to the pathophysiology of sepsis. Sepsis is now defined as a systemic inflammatory response syndrome (SIRS) in which there is an identifiable focus of infection. SIRS can be also precipitated by non-infective events such as trauma, pancreatitis, and surgery. As a consequence of an overactive SIRS response, the function of various organ systems may be compromised, resulting in multiple organ dysfunction syndrome (MODS) and death. Production and activation of multiple proinflammatory genes are likely to play a key role in the pathogenesis of MODS development. This review article focuses on the molecular mechanisms and components involved in the pathogenesis of severe sepsis. This includes cellular targets of sepsis-inducing bacterial products and their signaling pathways with a major emphasis on transcription factors and new therapeutic approaches to severe sepsis.|*Gene Silencing[MESH]|*Genetic Therapy/methods[MESH]|Animals[MESH]|Cytokines/metabolism[MESH]|Humans[MESH]|Macrophage Migration-Inhibitory Factors/genetics/metabolism[MESH]|NF-kappa B/genetics/metabolism[MESH]|Oligonucleotides, Antisense/genetics/*metabolism[MESH]|Receptors, Interleukin-1/metabolism[MESH]|Systemic Inflammatory Response Syndrome/genetics/metabolism/*therapy[MESH]|Toll-Like Receptors/metabolism[MESH]|Transcription Factor AP-1/genetics/metabolism[MESH] |